OPDUALAG Trademark

Trademark Overview

On Friday, September 24, 2021, a trademark application was filed for OPDUALAG with the United States Patent and Trademark Office. The USPTO has given the OPDUALAG trademark a serial number of 97043730. The federal status of this trademark filing is REGISTERED as of Tuesday, December 26, 2023. This trademark is owned by Bristol-Myers Squibb Company. The OPDUALAG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of cancer
opdualag

General Information

Serial Number97043730
Word MarkOPDUALAG
Filing DateFriday, September 24, 2021
Status700 - REGISTERED
Status DateTuesday, December 26, 2023
Registration Number7255772
Registration DateTuesday, December 26, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 26, 2021
Primary Code005
First Use Anywhere DateTuesday, March 22, 2022
First Use In Commerce DateTuesday, March 22, 2022

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543
Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events

Event DateEvent Description
Tuesday, December 26, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 26, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, November 22, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 21, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, October 27, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 12, 2023USE AMENDMENT FILED
Thursday, October 26, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 23, 2023ASSIGNED TO EXAMINER
Thursday, October 12, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, August 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 2, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 2, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 25, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 21, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 27, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 27, 2022NON-FINAL ACTION E-MAILED
Monday, June 27, 2022NON-FINAL ACTION WRITTEN
Sunday, June 26, 2022ASSIGNED TO EXAMINER
Tuesday, October 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 28, 2021NEW APPLICATION ENTERED

Related Keywords

opdualag prevention cancer treatment human preparations pharmaceutical